Approvals/TGA/BETISTAVERT betahistine dihydrochloride 16 mg tablets blister packs

Approved

STANDARD

BETISTAVERT betahistine dihydrochloride 16 mg tablets blister packs

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 068f37645a4c18d8
Product Name: BETISTAVERT betahistine dihydrochloride 16 mg tablets blister packs
Artg Id: 212087
Artg Name: BETISTAVERT betahistine dihydrochloride 16 mg tablets blister packs
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2014-08-14
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

068f37645a4c18d8

Type

Standard